Cargando…
A rare case of eptifibatide-induced thrombocytopenia
Eptifibatide is a glycoprotein (GP) IIb/IIIa receptor antagonist, used for the treatment of acute coronary syndrome with high-risk features or ongoing ischemia. Several case reports have described thrombocytopenia as a rare side effect of eptifibatide administration. The exact mechanism remains uncl...
Autores principales: | Kamar, Khalil, MacDougall, Kira, Alsheikh, Mira, Parylo, Sara, Skaradinskiy, Yevgeniy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043518/ https://www.ncbi.nlm.nih.gov/pubmed/33889336 http://dx.doi.org/10.1080/20009666.2021.1871802 |
Ejemplares similares
-
A Case of Vancomycin-Induced Immune Thrombocytopenia
por: MacDougall, Kira N, et al.
Publicado: (2020) -
Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014) -
Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010) -
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020) -
Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)